The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.
Open accessAbstract
Microparticles are released during platelet activation in vitro and have been detected in vivo in syndromes of platelet activation. They have been reported to express both pro- and anticoagulant activities. Nevertheless, their functional significance has remained unresolved. To address the mechanism(s) of cellular activation by platelet microparticles, we examined their effects on platelets and endothelial cells. Activation of human platelets by diverse stimuli (thrombin, 0.1 U/ml; collagen, 4 microg/ml; and the calcium ionophore A23187, 1 microM) results in shedding of microparticles. Pretreatment of these particles, but not membrane fractions from resting platelets, with (s)PLA2 evokes a dose-dependent increase in platelet aggregation, intracellular [Ca2+] movement, and inositol phosphate formation. These effects localize to the arachidonic acid fraction of the microparticles and are mimicked by arachidonic acid isolated from them. However, platelet activation requires prior metabolism of microparticle arachidonic acid to thromboxane A2. Thus, pretreatment of platelets with the cyclooxygenase (COX) inhibitor, indomethacin (20 microM), the thromboxane antagonist SQ29,548 (1 microM), or the protein kinase C inhibitor GF109203X (5 microM) prevents platelet activation by microparticles. However, platelet microparticles fail to evoke an inositol phosphate response directly, via either of the cloned thromboxane receptor isoforms stably expressed in human embryonic kidney (HEK) 293 cells. Prelabeling platelets with [2H(8)] arachidonate was used to demonstrate platelet metabolism of the microparticle-derived substrate to thromboxane. Platelet microparticles can also induce expression of COX-2 and prostacyclin (PGI2) production, but not expression of COX-1, in human endothelial cells. These effects are prevented by pretreatment with actinomycin D (12 microM) or cycloheximide (5 microg/ml). Expression of COX-2 is again induced by the microparticle arachidonate fraction, which it may then use to synthesize PGI2. Both PGE2 and iloprost, a stable PGI2 analog, evoke human umbilical vein endothelial cell COX-2 expression, albeit with kinetics that differ from the response to platelet microparticles. These studies indicate a novel mechanism of transcellular lipid metabolism whereby platelet activation may be amplified or modulated by concentrated delivery of arachidonic acid to adjacent platelets and endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Jaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 6,856
Flow-mediated endothelial mechanotransduction
Davies, P. F. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.519 · Cited by 2,802
Rapid separation of lipid classes in high yield and purity using bonded phase columns.
Kaluzny, M. A., Duncan, L. A., Merritt, M. V., & Epps, D. E. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34412-6 · Cited by 964
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 684
Sims, P. J., Wiedmer, T., Esmon, C. T., Weiss, H. J., & Shattil, S. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71457-9 · Cited by 596
Fourcade, O., Simon, M.-F., Viodé, C., Rugani, N., Leballe, F., Ragab, A., Fournié, B., Sarda, L., & Chap, H. (1995) · Cell · doi:10.1016/0092-8674(95)90295-3 · Cited by 536
Seilhamer, J. J., Pruzanski, W., Vadas, P., Plant, S., Miller, J. A., Kloss, J., & Johnson, L. K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83549-9 · Cited by 533
Mayer, R. J., & Marshall, L. A. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.2.8440410 · Cited by 439
Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial Cells
Marcus, A. J., Weksler, B. B., Jaffe, E. A., & Broekman, M. J. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109967 · Cited by 380
Cited by
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Heijnen, H. F. G., Schiel, A. E., Fijnheer, R., Geuze, H. J., & Sixma, J. J. (1999) · Blood · doi:10.1182/blood.v94.11.3791 · Cited by 1,487
Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2006) · Leukemia · doi:10.1038/sj.leu.2404296 · Cited by 1,340
Exosomes/microvesicles as a mechanism of cell-to-cell communication
Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V., & Biancone, L. (2010) · Kidney International · doi:10.1038/ki.2010.278 · Cited by 1,178
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Self-citationMallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J.-M., & Tedgui, A. (2000) · Circulation · doi:10.1161/01.cir.101.8.841 · Cited by 883
Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange
Mause, S. F., & Weber, C. (2010) · Circulation Research · doi:10.1161/circresaha.110.226456 · Cited by 786
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer
Janowska‐Wieczorek, A., Wysoczynski, M., Kijowski, J., Marquez‐Curtis, L., Machalinski, B., Ratajczak, J., & Ratajczak, M. Z. (2005) · International Journal of Cancer · doi:10.1002/ijc.20657 · Cited by 768
The platelet contribution to cancer progression
BAMBACE, N. M., & HOLMES, C. E. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04131.x · Cited by 705
Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis
Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., & Weyrich, A. S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105058 · Cited by 697
Immunological processes in malaria pathogenesis
Schofield, L., & Grau, G. E. (2005) · Nature Reviews Immunology · doi:10.1038/nri1686 · Cited by 688
Emerging role of extracellular vesicles in inflammatory diseases
Buzas, E. I., György, B., Nagy, G., Falus, A., & Gay, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.19 · Cited by 677
Mallat, Z., Hugel, B., Ohan, J., Lesèche, G., Freyssinet, J.-M., & Tedgui, A. (1999) · Circulation · doi:10.1161/01.cir.99.3.348 · Cited by 638
Microparticles in cardiovascular diseases
VANWIJK, M., VANBAVEL, E., STURK, A., & NIEUWLAND, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00367-5 · Cited by 610
Mack, M., Kleinschmidt, A., Brühl, H., Klier, C., Nelson, P. J., Cihak, J., Plachý, J., Stangassinger, M., Erfle, V., & Schlöndorff, D. (2000) · Nature Medicine · doi:10.1038/77498 · Cited by 605
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Self-citationShimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576
Modulation of monocyte-endothelial cell interactions by platelet microparticles.
Barry, O. P., Praticò, D., Savani, R. C., & FitzGerald, G. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2592 · Cited by 544
Self-citationExosomes for targeted siRNA delivery across biological barriers
EL Andaloussi, S., Lakhal, S., Mäger, I., & Wood, M. J. A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.008 · Cited by 539
Cells in focus: endothelial cell
Sumpio, B. E., Timothy Riley, J., & Dardik, A. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00075-4 · Cited by 531
Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction
Boulanger, C. M., Scoazec, A., Ebrahimian, T., Henry, P., Mathieu, E., Tedgui, A., & Mallat, Z. (2001) · Circulation · doi:10.1161/hc4701.100516 · Cited by 510
Effects of Severe Hypertension on Endothelial and Platelet Microparticles
Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M., Aime, G., & Ahn, Y. S. (2003) · Hypertension · doi:10.1161/01.hyp.0000049760.15764.2d · Cited by 499
Turturici, G., Tinnirello, R., Sconzo, G., & Geraci, F. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00228.2013 · Cited by 483
“EV-contained lipids may also stimulate cytokine secretion and tissue-factor expression in endothelial cells, inhibit apoptosis of PMCs, and induce chemotaxis in some cell lines (16, 22, 49, 114).”
BackgroundSzajnik, M., Czystowska, M., Szczepanski, M. J., Mandapathil, M., & Whiteside, T. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011469 · Cited by 462
Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., & Freyssinet, J.-M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000246775.14471.26 · Cited by 460
Germain, S. J., Sacks, G. P., Soorana, S. R., Sargent, I. L., & Redman, C. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5949 · Cited by 454
Shed membrane microparticles from circulating and vascular cells in regulating vascular function
Martínez, M. C., Tesse, A., Zobairi, F., & Andriantsitohaina, R. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00842.2004 · Cited by 454
Delivery of chemotherapeutic drugs in tumour cell-derived microparticles
Tang, K., Zhang, Y., Zhang, H., Xu, P., Liu, J., Ma, J., Lv, M., Li, D., Katirai, F., Shen, G.-X., et al. (2012) · Nature Communications · doi:10.1038/ncomms2282 · Cited by 453
Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization
BRILL, A., DASHEVSKY, O., RIVO, J., GOZAL, Y., & VARON, D. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.007 · Cited by 433
Cell-derived microparticles in haemostasis and vascular medicine
Burnier, L., Fontana, P., Kwak, B. R., & Angelillo-Scherrer, A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-08-0521 · Cited by 416
Microvesicles as Cell–Cell Messengers in Cardiovascular Diseases
Loyer, X., Vion, A.-C., Tedgui, A., & Boulanger, C. M. (2014) · Circulation Research · doi:10.1161/circresaha.113.300858 · Cited by 408
Cellular microparticles: what are they bad or good for?
Freyssinet, J.-M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00309.x · Cited by 399
Platelet-Endothelial Cell Interactions During Ischemia/Reperfusion: The Role of P-Selectin
Massberg, S., Enders, G., Leiderer, R., Eisenmenger, S., Vestweber, D., Krombach, F., & Messmer, K. (1998) · Blood · doi:10.1182/blood.v92.2.507 · Cited by 393
EVpedia: a community web portal for extracellular vesicles research
Kim, D.-K., Lee, J., Kim, S. R., Choi, D.-S., Yoon, Y. J., Kim, J. H., Go, G., Nhung, D., Hong, K., Jang, S. C., et al. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu741 · Cited by 393
Microparticles, Vascular Function, and Atherothrombosis
Rautou, P.-E., Vion, A.-C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., & Boulanger, C. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.233163 · Cited by 376
Circulating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease
Boulanger, C. M., Amabile, N., & Tedgui, A. (2006) · Hypertension · doi:10.1161/01.hyp.0000231507.00962.b5 · Cited by 372
Cellular microparticles: new players in the field of vascular disease?
Diamant, M., Tushuizen, M. E., Sturk, A., & Nieuwland, R. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01355.x · Cited by 364
Diamant, M., Nieuwland, R., Pablo, R. F., Sturk, A., Smit, J. W. A., & Radder, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000036596.59665.c6 · Cited by 359
Cocoa inhibits platelet activation and function
Rein, D., Paglieroni, T. G., Wun, T., Pearson, D. A., Schmitz, H. H., Gosselin, R., & Keen, C. L. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.1.30 · Cited by 358
Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases
Ståhl, A.-L., Johansson, K., Mossberg, M., Kahn, R., & Karpman, D. (2019) · Pediatric Nephrology · doi:10.1007/s00467-017-3816-z · Cited by 356
Mesri, M., & Altieri, D. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23111 · Cited by 349
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18012 · Cited by 341
Self-citationBaj-Krzyworzeka, M., Majka, M., Pratico, D., Ratajczak, J., Vilaire, G., Kijowski, J., Reca, R., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00791-9 · Cited by 329
Self-citationDonoso‐Quezada, J., Ayala‐Mar, S., & González‐Valdez, J. (2021) · Traffic · doi:10.1111/tra.12803 · Cited by 327
The role of microparticles in the pathogenesis of rheumatic diseases
Beyer, C., & Pisetsky, D. S. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.229 · Cited by 324
Chirinos, J. A., Heresi, G. A., Velasquez, H., Jy, W., Jimenez, J. J., Ahn, E., Horstman, L. L., Soriano, A. O., Zambrano, J. P., & Ahn, Y. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.075 · Cited by 323
Simak, J., & Gelderman, M. P. (2006) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2005.08.001 · Cited by 314
Platelets as Cellular Effectors of Inflammation in Vascular Diseases
Rondina, M. T., Weyrich, A. S., & Zimmerman, G. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.300512 · Cited by 312
Rak, J. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1267043 · Cited by 301
Huber, J., Vales, A., Mitulovic, G., Blumer, M., Schmid, R., Witztum, J. L., Binder, B. R., & Leitinger, N. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.101525 · Cited by 296
Extracellular vesicles in renal disease
Karpman, D., Ståhl, A.-L., & Arvidsson, I. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.98 · Cited by 295
Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome
Agouni, A., Lagrue-Lak-Hal, A. H., Ducluzeau, P. H., Mostefai, H. A., Draunet-Busson, C., Leftheriotis, G., Heymes, C., Martinez, M. C., & Andriantsitohaina, R. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080228 · Cited by 289
Clinical relevance of microparticles from platelets and megakaryocytes
Italiano, J. E., Mairuhu, A. T., & Flaumenhaft, R. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32833e77ee · Cited by 289
Sabatier, F., Roux, V., Anfosso, F., Camoin, L., Sampol, J., & Dignat-George, F. (2002) · Blood · doi:10.1182/blood.v99.11.3962 · Cited by 288
Schmassmann, A., Peskar, B. M., Stettler, C., Netzer, P., Stroff, T., Flogerzi, B., & Halter, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701672 · Cited by 287
Frantzeskaki, F., Armaganidis, A., & Orfanos, S. E. (2017) · Respiration · doi:10.1159/000453002 · Cited by 274
Prokopi, M., Pula, G., Mayr, U., Devue, C., Gallagher, J., Xiao, Q., Boulanger, C. M., Westwood, N., Urbich, C., Willeit, J., et al. (2009) · Blood · doi:10.1182/blood-2009-02-205930 · Cited by 273
Sprague, D. L., Elzey, B. D., Crist, S. A., Waldschmidt, T. J., Jensen, R. J., & Ratliff, T. L. (2008) · Blood · doi:10.1182/blood-2007-06-097410 · Cited by 262
Rautou, P.-E., Leroyer, A. S., Ramkhelawon, B., Devue, C., Duflaut, D., Vion, A.-C., Nalbone, G., Castier, Y., Leseche, G., Lehoux, S., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.237420 · Cited by 255
The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue Repair
Oggero, S., Austin-Williams, S., & Norling, L. V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01479 · Cited by 85
Metadata
- Authors
- Barry, O. P., Pratico, D., Lawson, J. A., & FitzGerald, G. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-05-01
- Volume
- 99
- Issue
- 9
- Pages
- 2118-2127
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1972365386
- Cited by
- 480
- References
- 28
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.